Montelukast
Back to searchMolecule Structure
Scientific Name
Montelukast
Description of the Drug
Montelukast is a leukotriene receptor antagonist used as part of an asthma therapy regimen, to prevent exercise induced bronchoconstriction, and to treat seasonal allergic rhinitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00471
http://www.drugbank.ca/drugs/DB00471
Brand Name(s)
Singulair
Company Owner(s)
Cipla Ltd, Unimark Remedies Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Torrent Pharmaceuticals Ltd, Apotex Corp, Ajanta Pharma Ltd, Anbison Laboratory Co Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cysteinyl leukotriene receptor 1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL1798 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4486 | ||
PharmGKB | PA450546 | ||
Human Metabolome Database | HMDB0014614 | ||
DrugBank | DB00471 | ||
PubChem: Thomson Pharma | 14886896 | 14886895 | |
PubChem | 5281040 | ||
LINCS | LSM-43228 | ||
Nikkaji | J870.100H | J2.625.694A | |
PDBe | MTK | ||
BindingDB | 50052024 | ||
EPA CompTox Dashboard | DTXSID9023334 | ||
DrugCentral | 1836 | ||
ChemicalBook | CB7112818 | ||
Guide to Pharmacology | 3340 | ||
rxnorm | MONTELUKAST SODIUM | MONTELUKAST | SINGULAIR |
KEGG Ligand | C07482 | ||
ChEBI | 50730 | ||
ZINC | ZINC000003831151 |